Free Trial
BATS:HELX

Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)
Free HELX Stock Alerts
$29.95
-0.51 (-1.67%)
(As of 04/25/2024 ET)
Compare
Today's Range
$29.95
▼
$29.95
50-Day Range
$29.32
▼
$32.92
52-Week Range
N/A
Volume
163 shs
Average Volume
N/A
Market Capitalization
$8.99 million
Assets Under Management
$9.04 million
Dividend Yield
N/A
Net Expense Ratio
0.50%
Stock AnalysisChartHoldingsRatings

About Franklin Genomic Advancements ETF

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.

HELX Stock Price History

HELX ETF News Headlines

April 23, 2024 | lse.co.uk
Franklin Catholic Princ Em Sov Ucits Etf Share Price (CATHEM.MI)
March 27, 2024 | money.usnews.com
Franklin U.S. Treasury Bond ETF
April 27, 2024 | True Market Insiders (Ad)
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
November 25, 2023 | lse.co.uk
Franklin Msci China Paris Alig Ucits Etf Share Price (FRCP.MI)
November 17, 2023 | lse.co.uk
Franklin Emerging Markets Ucits Etf Share Price (FLXE.MI)
February 25, 2023 | morningstar.com
BMO ARK Genomic Revolution ETF Series
See More Headlines
Receive HELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Franklin Templeton Investments
Fund Name
Franklin Genomic Advancements ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:HELX
Inception Date
2/25/2020
Fund Manager
Matthew J.Moberg, Joyce Lin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
65

Fund Statistics

Assets Under Management
$9.04 million
Average Daily Volume
$0.00
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
Franklin Templeton Services, LLC
Advisor
Franklin Advisers, Inc.
Custodian
State Street Bank and Trust Company
Distributor
Franklin Templeton Distributors, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Miscellaneous

Outstanding Shares
300,000
Beta
0.96
Creation Unit
50,000
Creation Fee
$200.00
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Ad True Market Insiders
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Click For My #1 FREE Crypto for 2024

Franklin Genomic Advancements ETF Expenses

TypeHELXTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.50%0.57%0.54%0.56%0.51%
Other Expenses0.00%0.72%0.54%0.51%0.58%
Total Expense0.50%0.72%0.70%0.68%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.34%-0.57%
Net Expense0.50%0.59%0.60%0.63%0.58%

Franklin Genomic Advancements ETF (HELX) Holdings & Exposure

Top 10 HELX Holdings

HELX Sector Exposure

HELX Industry Exposure

Full Holdings Details

HELX ETF - Frequently Asked Questions

How have HELX shares performed in 2024?

Franklin Genomic Advancements ETF's stock was trading at $30.47 at the beginning of 2024. Since then, HELX stock has decreased by 1.7% and is now trading at $29.9515.
View the best growth stocks for 2024 here.

What does HELX invest in?

Franklin Genomic Advancements ETF is a equity fund issued by Franklin Templeton Investments. HELX focuses on theme investments. The fund's investments total to approximately $9.04 million assets under management.

What stocks does Franklin Genomic Advancements ETF hold?

HELX invests in 65 holdings. Some of the stocks in their portfolio include Medpace (MEDP), Vertex Pharmaceuticals (VRTX), Thermo Fisher Scientific (TMO), Regeneron Pharmaceuticals (REGN), Eli Lilly and Company (LLY), Krystal Biotech (KRYS), Danaher (DHR), Bruker (BRKR), Natera (NTRA) and AstraZeneca (AZN).

What is the management fee for Franklin Genomic Advancements ETF?

Franklin Genomic Advancements ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for HELX is 0.50%.

How do I buy shares of Franklin Genomic Advancements ETF?

Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (BATS:HELX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The World's First "$20 Trillion Drug?"
Behind the Markets
Fed launches fourth dollar overhaul
Stansberry Research
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Man Who Predicted 2008: “This Will be Worse.”
Altimetry